Head and neck cancer Trials in New York, United States
Conditions / Head and neck cancer / New York, United States
Clinical trials for Head and neck cancer investigate a range of treatment strategies and patient populations.
135 total trials for this combination
Showing top 10 of 135 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05259696 | Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01) | COMPLETED | PHASE1/PHASE2 |
| NCT04383210 | Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors | TERMINATED | PHASE2 |
| NCT00588640 | Study of D-Methadone in Patients With Chronic Pain | COMPLETED | PHASE1/PHASE2 |
| NCT05864144 | A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2 |
| NCT06172478 | A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors | RECRUITING | PHASE2 |
| NCT00004065 | Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer | COMPLETED | PHASE1 |
| NCT00003103 | Chemotherapy in Treating Patients With Solid Tumors | COMPLETED | PHASE1/PHASE2 |
| NCT06673329 | Brodalumab in the Treatment of Immune-Related Adverse Events | RECRUITING | PHASE1 |
| NCT04585750 | The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) | RECRUITING | PHASE1/PHASE2 |
| NCT03329950 | A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies | COMPLETED | PHASE1 |